Natera

1 month ago

Associate Medical Director, Gynecologic Oncology

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI

Last checked: 23 hours agoStatus: Live

Job Summary

Lead clinical development and medical strategy for cfDNA/liquid biopsy in gynecologic oncology, focusing on MRD, recurrence monitoring, and clinical utility. Drive evidence generation, education, and cross-functional collaboration with R&D, commercial, and medical affairs to advance diagnostic solutions and oncology portfolio adoption.

Location: United States

Workplace: Remote

Employment Type: Full time

Job Function: Healthcare (Clinical, Medical, Wellness)

Key Responsibilities

•Partner with the Sr. Medical Director, Oncology on the clinical development of cfDNA molecular diagnostics and liquid biopsy assays for gynecologic cancers.
•Direct the development and execution of clinical strategies and evidence-generation plans that demonstrate clinical utility in gynecologic oncology, including MRD tracking, recurrence monitoring, treatment response assessment, and clinical trial enrichment.
•Oversee medical education and scientific communications for healthcare providers focused on gynecologic oncology, including tumor boards, webinars, and field medical enablement.
•Represent Natera at medical congresses and industry events, including SGO, ASCO, and ESMO, in person and virtually; build and maintain relationships with external experts and professional societies.
•Collaborate with R&D, biostatistics, clinical operations, and HEOR on protocol development, endpoint selection, data analysis, publications, and congress submissions in gynecologic oncology.

Pay and Benefits

Salary: USD 188,500 - 235,600 annually

Equity and Bonus:Equity

Perks:Health Insurance401kPaid LeaveEquity

Key Requirements

•M.D. or D.O. with board certification in Gynecologic Oncology, or Medical Oncology with a significant gynecologic oncology focus.
•Minimum 5 years of post-training experience in oncology with a strong background in clinical research and development; clinical diagnostics or biopharma industry experience is preferred.
•At least 3 years of clinical trial experience in academia, biopharma, biotech, diagnostics, or an equivalent clinical research setting.
•Ability to communicate credibly across solid tumor histologies and indications to support cross-portfolio initiatives.
•Excellent written and oral communication skills with strong presentation, scientific storytelling, and real-time problem-solving abilities.

Experience:OncologyClinical researchBiopharmaGynecologic oncology

Education:Professional (JD, MD, etc.)

Skills:CommunicationLeadershipProject managementCross-functional collaborationScientific storytelling

Languages:English

Tech Stack:Clinical researchBiostatisticsRegulatoryEndpoint designProtocol development

Company Brief

Natera

Develops and commercializes genetic testing and diagnostics focused on reproductive health, oncology, and organ transplant to inform clinical decision-making and improve patient outcomes.

Industry: Diagnostics

Company Size: Enterprise (1,001+ employees)

Revenue: USD 500M to 1B

Growth: Public Company

Valuation: Public Company (Market Cap in USD)

Funding: IPO / Publicly Listed

Headquarters: San Carlos, United States

Founded: 2004

Website LinkedIn

Loading job details...

Preparing the role view and application actions.

Natera

1 month ago

Associate Medical Director, Gynecologic Oncology

✓ Verified Job

Canonical indexed version, validated from employer's careers page.

Source: Company careers pageValidated by: Fursa AI

Last checked: 23 hours agoStatus: Live

Job Summary

Location: United States

Workplace: Remote

Employment Type: Full time

Job Function: Healthcare (Clinical, Medical, Wellness)

Key Responsibilities

•Partner with the Sr. Medical Director, Oncology on the clinical development of cfDNA molecular diagnostics and liquid biopsy assays for gynecologic cancers.
•Direct the development and execution of clinical strategies and evidence-generation plans that demonstrate clinical utility in gynecologic oncology, including MRD tracking, recurrence monitoring, treatment response assessment, and clinical trial enrichment.
•Oversee medical education and scientific communications for healthcare providers focused on gynecologic oncology, including tumor boards, webinars, and field medical enablement.
•Represent Natera at medical congresses and industry events, including SGO, ASCO, and ESMO, in person and virtually; build and maintain relationships with external experts and professional societies.
•Collaborate with R&D, biostatistics, clinical operations, and HEOR on protocol development, endpoint selection, data analysis, publications, and congress submissions in gynecologic oncology.

Pay and Benefits

Salary: USD 188,500 - 235,600 annually

Equity and Bonus:Equity

Perks:Health Insurance401kPaid LeaveEquity

Key Requirements

•M.D. or D.O. with board certification in Gynecologic Oncology, or Medical Oncology with a significant gynecologic oncology focus.
•Minimum 5 years of post-training experience in oncology with a strong background in clinical research and development; clinical diagnostics or biopharma industry experience is preferred.
•At least 3 years of clinical trial experience in academia, biopharma, biotech, diagnostics, or an equivalent clinical research setting.
•Ability to communicate credibly across solid tumor histologies and indications to support cross-portfolio initiatives.
•Excellent written and oral communication skills with strong presentation, scientific storytelling, and real-time problem-solving abilities.

Experience:OncologyClinical researchBiopharmaGynecologic oncology

Education:Professional (JD, MD, etc.)

Skills:CommunicationLeadershipProject managementCross-functional collaborationScientific storytelling

Languages:English

Tech Stack:Clinical researchBiostatisticsRegulatoryEndpoint designProtocol development

Company Brief

Natera

Develops and commercializes genetic testing and diagnostics focused on reproductive health, oncology, and organ transplant to inform clinical decision-making and improve patient outcomes.

Industry: Diagnostics

Company Size: Enterprise (1,001+ employees)

Revenue: USD 500M to 1B

Growth: Public Company

Valuation: Public Company (Market Cap in USD)

Funding: IPO / Publicly Listed

Headquarters: San Carlos, United States

Founded: 2004

Website LinkedIn